MARKETS PERPS LIVE99

Cash

Trending Elections Politics Culture Sports Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live99 AccountSocial

Reminder: Weekly scheduled exchange maintenance will occur from 3-5 AM ET. Trading will be paused during this time.

Product

Kalshi Pro Perpetual Futures Markets Incentive program Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Medicine

When will Intellia Therapeutics submit a BLA for Lonvo-z?

Series Image

Medicine

When will Intellia Therapeutics submit a BLA for Lonvo-z?

before October

Yes

before October

Yes

before November

Yes

before November

Yes

before 2027

Yes

before 2027

Yes

3 more

Determined

Outcome: No

Explore General

$19,397 vol

1D

1W

1M

ALL